by Vandana Singh | Nov 6, 2026 | General
On Thursday, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Johnson & Johnson’s (NYSE:JNJ) Rybrevant Faspro as a single agent for adults battling recurrent or metastatic head and neck squamous cell carcinoma (HCSCC). Eligible patients...
by Vandana Singh | Nov 6, 2026 | General
Moderna Inc. (NASDAQ:MRNA) stock traded higher Friday after the vaccine maker reported better-than-expected third-quarter results and raised its full-year revenue outlook above Wall Street estimates. Stronger international COVID-19 vaccine sales, lower research...
by Earnings Transcripts | Nov 6, 2026 | General
Skyward Specialty (NASDAQ:SKWD) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog,...
by Earnings Transcripts | Nov 6, 2026 | General
Marcus & Millichap (NYSE:MMI) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog,...
by Benzinga Insights | Nov 6, 2026 | General
Vanguard Morningstar Mega Cap Growth ETF (NYSE:MGK) has outperformed the market over the past 10 years by 4.19% on an annualized basis producing an average annual return of 17.24%. Currently, Vanguard Morningstar Mega Cap Growth ETF has a market capitalization of...
by Earnings Transcripts | Nov 6, 2026 | General
Howard Hughes Holdings (NYSE:HHH) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog,...
Recent Comments